null
100% Quality Guarantee
PhD-Level Technical Support
Key Features

PE Anti-Mouse CD279/PD-1 Antibody [29F.1A12] (AGEL1628)

SKU AGEL1628
Product Type Antibody
Antibody Type Monoclonal Antibody
Applications FC
Reactivity Mouse
Host Species Rat
Isotype IgG2a,k
Clone 29F.1A12
Conjugation PE
€57 - €144
Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

PE Anti-Mouse CD279/PD-1 Antibody [29F.1A12]

The Mouse CD279 (PD-1) Monoclonal Antibody (PE Conjugated) 29F.1A12 (AGEL1628) is a cutting-edge tool for researchers delving into immune checkpoint pathways. This antibody, specifically designed for detecting the CD279 (PD-1) protein in mouse samples, offers high specificity and sensitivity, making it a reliable choice for flow cytometry applications. By binding to CD279 (PD-1), this antibody allows for precise identification and analysis of immune cells expressing this critical immune checkpoint marker.CD279 (PD-1) is a key immune checkpoint receptor that plays a crucial role in maintaining immune tolerance and preventing autoimmunity. Its dysregulation has been implicated in various diseases, particularly cancer, where it enables tumor cells to evade immune surveillance.

Research on CD279 (PD-1) is instrumental in developing novel immunotherapies that target this pathway to enhance anti-tumor immune responses.The Mouse CD279 (PD-1) Monoclonal Antibody (PE Conjugated) 29F.1A12 (AGEL1628) provides a valuable tool for investigating the role of CD279 (PD-1) in immune regulation and disease pathogenesis. Its application in flow cytometry assays offers researchers the ability to characterize immune cell populations and study the impact of CD279 (PD-1) signaling in various experimental settings. Unlock the potential of immune checkpoint modulation with this specialized antibody designed to advance immunology and cancer research.

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose